Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

@article{Swanson2001ClinicalRO,
  title={Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.},
  author={J. Swanson and H. Kraemer and S. Hinshaw and L. E. Arnold and C. Conners and H. Abikoff and W. Clevenger and M. Davies and G. Elliott and L. Greenhill and L. Hechtman and B. Hoza and P. Jensen and J. March and J. Newcorn and E. Owens and W. Pelham and E. Schiller and J. Severe and S. Simpson and B. Vitiello and K. Wells and T. Wigal and M. Wu},
  journal={Journal of the American Academy of Child and Adolescent Psychiatry},
  year={2001},
  volume={40 2},
  pages={
          168-79
        }
}
  • J. Swanson, H. Kraemer, +21 authors M. Wu
  • Published 2001
  • Psychology, Medicine
  • Journal of the American Academy of Child and Adolescent Psychiatry
  • OBJECTIVES To develop a categorical outcome measure related to clinical decisions and to perform secondary analyses to supplement the primary analyses of the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA). METHOD End-of-treatment status was summarized by averaging the parent and teacher ratings of attention-deficit/hyperactivity disorder and oppositional defiant disorder symptoms on the Swanson, Nolan, and Pelham… CONTINUE READING
    869 Citations

    Paper Mentions

    Interventional Clinical Trial
    This study evaluates the use of Rhodiola rosea in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in adults. Half of participants will receive Rhodiola rosea… Expand
    ConditionsAttention Deficit/Hyperactivity Disorder
    InterventionDrug
    Interventional Clinical Trial
    This trial is a continuation of the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (MTA Study). Continuation Aim 1 is to track the persistence of… Expand
    ConditionsAttention Deficit Disorder With Hyperactivity, Dyssocial Behavior, Substance-related Disorders
    InterventionBehavioral, Drug
    Multimodal treatment of ADHD in the MTA: an alternative outcome analysis.
    • 264
    Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers
    • 509
    Introduction--ADHD comorbidity and treatment outcomes in the MTA.
    • P. Jensen
    • Psychology, Medicine
    • Journal of the American Academy of Child and Adolescent Psychiatry
    • 2001
    • 40
    3-year follow-up of the NIMH MTA study.
    • 570
    • PDF
    Attention-deficit hyperactivity disorder, multimodal treatment, and longitudinal outcome: evidence, paradox, and challenge.
    • 52

    References

    SHOWING 1-10 OF 21 REFERENCES
    Multimodal treatment of ADHD in the MTA: an alternative outcome analysis.
    • 264
    Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study.
    • 73
    • Highly Influential
    Behavioral Characteristics of DSM-IV ADHD Subtypes in a School-Based Population
    • 386
    Attention-deficit hyperactivity disorder and hyperkinetic disorder
    • 647
    Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.
    • 6,608
    • PDF
    Reporting the size of effects in research studies to facilitate assessment of practical or clinical significance
    • H. Kraemer
    • Psychology, Medicine
    • Psychoneuroendocrinology
    • 1992
    • 66